New Data Reveals Metformin’s Role in Early Pregnancy Success – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Don’t Stop Metformin at a Positive Test: New Data Shows Continuing Through Trimester 1 Cut Miscarriage Risk in Half
A massive new systematic review and meta-analysis published in the American Journal of Obstetrics and Gynaecology analysed data from over 1,700 women to settle the debate on metformin timing. The results showed that continuing metformin through the first trimester significantly boosted clinical pregnancy rates and reduced the odds of miscarriage by over 50% compared to stopping immediately upon confirmation. Researchers propose that abrupt stopping causes a harmful ‘insulin rebound’ effect during critical early fetal development.
A systematic review and meta-analysis of 12 Randomized Controlled Trials (n=1,708) published in the American Journal of Obstetrics and Gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 7, 2026, 16:23Amelia Degenkolb: ACOG 2026 Brings Innovation, Partnership and Patient Access Into Focus
-
May 7, 2026, 16:15New FIGO-IPPS Classification for Female Chronic Pelvic Pain – IJGO
-
May 7, 2026, 16:05Marco Zaccaria: How Uterine Fibroids Affect Latina Women
-
May 7, 2026, 12:36Adela Serban: Advanced Imaging Technique Enhances Uterine Imaging with 3D Ultrasound and Uterine Tracing
-
May 7, 2026, 12:26David Sable Highlights The Quest for Fertility as a Deep and Valuable Read
-
May 7, 2026, 12:20May Is Preeclampsia Awareness Month – The Society for Maternal-Fetal Medicine
-
May 7, 2026, 12:15PCOS Symptoms Should Not Be Dismissed – PCOS Awareness Association
-
May 7, 2026, 12:08Marco Zaccaria: The Role of the Junctional Zone in the Management of Adenomyosis With Infertility
-
May 7, 2026, 12:04Emad Sedeek: Understanding the Differences in PGT-A, PGT-M and PGT-P Embryogenetic Testing